Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Browse by Category: Main > Health & Medicine
Class Information
Number: 514/368
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) > 1,3-thiazoles (including hydrogenated) > Polycyclo ring system having the thiazole ring as one of the cyclos > Bicyclo ring system having the thiazole ring as one of the cyclos > Ring nitrogen is shared by the cyclos of the bicyclo ring system (e.g., tetramisole, etc.)
Description: Subject matter wherein the ring nitrogen is a member of both of the cyclos in the bicyclo ring system, e.g., tetramisole etc.










Patents under this class:
1 2 3 4

Patent Number Title Of Patent Date Issued
8658425 Method for promoting differentiation of pluripotent stem cells into cardiac muscle cells Feb. 25, 2014
8530504 Pyrazolothiazole compound Sep. 10, 2013
8431603 3-phenylpyrazolo[5,1-b]thiazole compounds Apr. 30, 2013
8404729 Heterocyclic tetracyclic tetrahydrofuran derivatives Mar. 26, 2013
8263631 Anti-cancer pharmaceutical compositions and methods for treating patients with cancer Sep. 11, 2012
8252822 Heterocyclic compounds and uses as anticancer agents Aug. 28, 2012
8227427 Veterinarian composition comprising an organic salt of levamisole in combination with at least one avermectin and/or milbemycin Jul. 24, 2012
8138210 Substituted indanyl sulfonamide compounds, their preparation and use as medicaments Mar. 20, 2012
8138182 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient Mar. 20, 2012
8080569 Imidazo[2,1-b]thiazoles and their use as pharmaceuticals Dec. 20, 2011
7893069 Substituted imidazo[2,1-b]thiazole compounds and uses thereof Feb. 22, 2011
7838513 Anti-cancer therapy comprising an H2-blocker, at least one antiinflammatory agent and a cytotoxic agent Nov. 23, 2010
7790741 Imidazothiazoles and imidazoxazoles Sep. 7, 2010
7671078 Isothiourea derivatives of imadazo[2,1-b]Thiazoles and 5,6-dihydro derivatives thereof useful as CXCR4 chemokine receptor inhibitors Mar. 2, 2010
7662841 Imidazothiazole derivatives and process for producing the same Feb. 16, 2010
7514458 Anti-cytokine heterocyclic compounds Apr. 7, 2009
7498327 Indolylalkylamine metabolites as 5-hydroxytryptamine-6 ligands Mar. 3, 2009
7419993 Triazolo-epothilones Sep. 2, 2008
7351732 Cycloalkanedione derivatives, method for the production thereof and their pharmacological applications Apr. 1, 2008
7345069 Oxidative activation and episulfonium ion-mediated DNA alkylation-based anticancer Mar. 18, 2008
7288559 Carboxamide spirohydantoin CGRP receptor antagonists Oct. 30, 2007
7230021 Potent, simplified derivatives of pateamine A Jun. 12, 2007
7220756 N-sulfonylheterocyclopyrrolyl-alkylamine compounds as 5-hydroxytryptamine-6 ligands May. 22, 2007
7153873 Salts of bicyclic, N-acylated imidazo-3-amines and imidazo-5-amines Dec. 26, 2006
7125863 Inhibitors of dipeptidyl peptidase IV Oct. 24, 2006
7105550 2,4-disubstituted thiazolyl derivatives Sep. 12, 2006
7087626 Pyrrole derivatives as pharmaceutical agents Aug. 8, 2006
7022701 Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands Apr. 4, 2006
7012087 p53 inhibitors and therapeutic use of the same Mar. 14, 2006
7008957 Bicyclic cyanoheterocycles, process for their preparation and their use as medicaments Mar. 7, 2006
6900160 Triazolo-epothilones May. 31, 2005
6875765 Arylsulfonamide ethers, and methods of use thereof Apr. 5, 2005
6838462 Insecticidal azoles Jan. 4, 2005
6821993 Triazepine derivatives as neurotrophic agents Nov. 23, 2004
6794359 Vertebrate intestinal protein which absorbs cholesterol, its inhibitors and mehtod of identifying the same Sep. 21, 2004
6770642 Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands Aug. 3, 2004
6730686 Methods for inhibiting oxidative modification of proteins May. 4, 2004
6696441 Inhibition of p53-induced stress response Feb. 24, 2004
6670128 Transfusion medicine leukodepletion filter devices as a source of genetic material for genotyping studies Dec. 30, 2003
6586452 C1 to C4 side chain modified nodulisporic acid analogs Jul. 1, 2003
6586426 .beta.-sheet mimetics and use thereof as protease inhibitors Jul. 1, 2003
6586419 Phototherapeutic inactivation of ocular viruses Jul. 1, 2003
6440963 Use of selective COX-2 inhibitors for the treatment of urinary incontinence Aug. 27, 2002
6395724 Multibinding inhibitors of cyclooxygenase-2 May. 28, 2002
6380228 Inhibitors of prenyl-protein transferase Apr. 30, 2002
6362191 Aminometyl oxooxazolidinyl benzene derivatives Mar. 26, 2002
6313090 Methods for treating parasitic infection using thiopeptides Nov. 6, 2001
6299865 Reduction of hair growth Oct. 9, 2001
6242470 Adamantane derivatives Jun. 5, 2001
6177454 Amide derivatives and medicinal compositions thereof Jan. 23, 2001

1 2 3 4










 
 
  Recently Added Patents
Instance management of code in a database
Critical word forwarding with adaptive prediction
Continuously variable transmission and control method thereof
Wristband with detachable labels
Systems and methods for excluding undesirable network transactions
All-angle light emitting element having high heat dissipating efficiency
PCSK9 antagonists
  Randomly Featured Patents
Pipe nipple protective sleeve
Automatic focusing system for scanning electron microscope equipped with laser defect detection function
System for automatic hardware identification and configuration where instance values are unique within the computer system and resource requirement conflicts are resolved by modifying resource
Method and device for the location of a mobile telephone in a communications network
Friction yarn false twisting apparatus
Fittable pipette tip consisting of a vessel which is designed to fit a particularly conical fitting head of a pipette
Process for synthesizing C5+ hydrocarbons in the presence of a catalyst prepared using at least one cyclic oligosaccharide
3-dehydroquinate synthase
RF/VHF plasma diamond growth method and apparatus and materials produced therein
Method for the production of a cell and/or tissue and/or disease phase specific medicament